Molecular Targets 2021: Examining Synthetic Lethality Beyond PARP Inhibitors
Cancer is a very complex disease. Cancer cells often have the ability to rewire some of their functions to survive in harsh...
Tag: FDA approvals
Cancer is a very complex disease. Cancer cells often have the ability to rewire some of their functions to survive in harsh...
Roughly 6 percent of men and women in the United States will be diagnosed with lung and bronchus cancer...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
Bladder cancer is a common malignancy originating in the bladder, a hollow organ located in the abdomen that stores urine. It is the sixth most prevalent cancer in the United...
Over the course of the two-day AACR Virtual Annual Meeting I, more than 61,000 people from 140 countries around the...
Head and neck cancers encompass a large group of malignancies that originate in the nasal cavity, sinuses, lips, mouth,...
A highly complex filtering system, the kidneys process roughly half a cup of blood every minute, isolating waste and...
The first new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) in 2020 are for the...